Immunic Announces Publication of Extended Data From Phase 2 Emphasis Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
Immunic宣佈在同行評審期刊《神經病學® 神經免疫學與神經炎症》上發佈Vidofludimus鈣治療復發緩解型多發性硬化症的2期重點試驗的擴展數據